Literature DB >> 24488737

Sporadic fatal insomnia in an adolescent.

Jennifer L Blase1, Laura Cracco, Lawrence B Schonberger, Ryan A Maddox, Yvonne Cohen, Ignazio Cali, Ermias D Belay.   

Abstract

The occurrence of sporadic prion disease among adolescents is extremely rare. A prion disease was confirmed in an adolescent with disease onset at 13 years of age. Genetic, neuropathologic, and biochemical analyses of the patient's autopsy brain tissue were consistent with sporadic fatal insomnia, a type of sporadic prion disease. There was no evidence of an environmental source of infection, and this patient represents the youngest documented case of sporadic prion disease. Although rare, a prion disease diagnosis should not be discounted in adolescents exhibiting neurologic signs. Brain tissue testing is necessary for disease confirmation and is particularly beneficial in cases with an unusual clinical presentation.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; adolescent; prion disease; sporadic fatal insomnia; transmissible spongiform encephalopathy

Mesh:

Year:  2014        PMID: 24488737      PMCID: PMC3934327          DOI: 10.1542/peds.2013-1396

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

1.  Rapidly progressive dementia in a patient who received a cadaveric dura mater graft.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-02-06       Impact factor: 17.586

Review 2.  Transmissible spongiform encephalopathies in humans.

Authors:  E D Belay
Journal:  Annu Rev Microbiol       Date:  1999       Impact factor: 15.500

3.  Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.

Authors:  T K Koch; B O Berg; S J De Armond; R F Gravina
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

4.  Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.

Authors:  C J Gibbs; A Joy; R Heffner; M Franko; M Miyazaki; D M Asher; J E Parisi; P W Brown; D C Gajdusek
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

Review 5.  Sporadic human prion diseases: molecular insights and diagnosis.

Authors:  Gianfranco Puoti; Alberto Bizzi; Gianluigi Forloni; Jiri G Safar; Fabrizio Tagliavini; Pierluigi Gambetti
Journal:  Lancet Neurol       Date:  2012-07       Impact factor: 44.182

6.  Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report.

Authors:  V Thadani; P L Penar; J Partington; R Kalb; R Janssen; L B Schonberger; C S Rabkin; J W Prichard
Journal:  J Neurosurg       Date:  1988-11       Impact factor: 5.115

7.  Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-06-21       Impact factor: 17.586

8.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.

Authors:  S B Prusiner; M Scott; D Foster; K M Pan; D Groth; C Mirenda; M Torchia; S L Yang; D Serban; G A Carlson
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

Review 9.  Sporadic and familial CJD: classification and characterisation.

Authors:  Pierluigi Gambetti; Qingzhong Kong; Wenquan Zou; Piero Parchi; Shu G Chen
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

10.  Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells.

Authors:  A Taraboulos; D Serban; S B Prusiner
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

View more
  2 in total

Review 1.  A review of drug therapy for sporadic fatal insomnia.

Authors:  Pardis Tabaee Damavandi; Martin T Dove; Richard W Pickersgill
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

2.  Understanding and exploiting interactions between cellular proteostasis pathways and infectious prion proteins for therapeutic benefit.

Authors:  Unekwu M Yakubu; Celso S G Catumbela; Rodrigo Morales; Kevin A Morano
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.